ボーンワックスの世界市場：2024年～2031年

市場概要

ボーンワックスの世界市場は、2023年に6,560万米ドルに達し、2031年には8,200万米ドルに達すると予測されており、予測期間2024年～2031年のCAGRは2.8%で成長すると予測されています。

ボーンワックスは、整形外科、神経外科、胸部外科で一般的に使用される無菌手術用製品です。蜜蝋と石油ゼリーの混合物で構成され、パルミチン酸イソプロピルやラノリンなどの物質が添加されることもあります。ボーンワックスは汎用性があり、凹凸や小さな欠損を含む様々な骨表面に塗布することができます。柔軟性があるため、成形や塗布が容易で、幅広い外科手術に適しています。

ボーンワックスは、長年にわたり外科手術の標準的なツールであり、その安全性と有効性は実証済みです。その重要性は、様々な外科専門分野で広く使用され、標準的な手術プロトコールに含まれていることからも明らかです。ボーンワックスは、外科医が血液のない透明な環境で作業できるようにすることで、手術の精度を高めます。この透明性により手術部位の視認性が向上し、外科医はより正確で信頼性の高い繊細な手術を行うことができます。

市場力学：

促進要因と抑制要因

スポーツやレクリエーション関連の怪我の増加

スポーツやレクリエーションに関連した怪我は、特に脛骨、腓骨、大腿骨などの体重のかかる骨の骨折につながることが多いです。骨折修復手術の際、骨表面からの出血を抑えるために、特に軟部組織に大きな外傷がある場合にはボーンワックスが頻繁に使用されます。スポーツ傷害による骨折の発生率の増加は、ボーンワックスの需要と直結しています。

例えば、ジョンズ・ホプキンス大学2022年発表の論文によると、米国では約3,000万人の子供と10代の若者が何らかの形で組織化されたスポーツに参加しており、毎年350万人以上の参加者が何らかの参加時間の損失を引き起こす怪我を経験していると推定されています。小児期に発生する全怪我のほぼ3分の1がスポーツ関連の怪我です。

また、2020年3月に発表されたWeinstein Legal Teamの報告書によると、米国では毎年3,000万人近くの子供や青年が青少年スポーツに参加しています。これは整形外科的な緊急事態につながる可能性があり、手術やボーンワックスの需要につながるため、市場成長の原動力となっています。さらに、スポーツ外傷は、多発骨折、脱臼、骨の変形など、外科的介入を必要とする複雑な外傷を引き起こす可能性があります。

市場力学：

抑制要因

代替止血剤の出現

合成シーラント、止血ゲル、高度止血パウダーなどの代替止血剤の市場開拓は、ボーンワックス市場の成長にとって課題となる可能性があります。外科医は、特に迅速な止血や生分解性といった特殊な特性が望まれる場合には、従来のボーンワックスよりもこれらの新しい製品を選ぶ可能性があります。

代替止血剤は、迅速な止血、使いやすさ、生分解性、安全性の向上といった特定の特性において、ボーンワックスよりも優れている可能性があります。例えば、Ostene骨止血材のようなバクスター製品はボーンワックスの代替品です。さらに、新しい止血材は、規制当局の承認を得るために厳格な試験と臨床評価が行われ、安全性と有効性の基準に適合していることが保証されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • スポーツやレクリエーションに関連する傷害の増加
    • 製品の技術的進歩の高まり
• 抑制要因
  • 代替止血剤の出現
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• アンメットニーズ
• DMIの見解

第6章 COVID-19分析

第7章 製品別

• 吸収性ボーンワックス
• 非吸収性ボーンワックス

第8章 材料別

• 天然ボーンワックス
• 合成ボーンワックス

第9章 用途別

• 胸部外科
• 整形外科
• 歯科/口腔外科
• 脳神経外科
• その他

第10章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• その他

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第12章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第13章 企業プロファイル

• B. Braun SE
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Cura Medical
• Dolphin Sutures
• GPC Medical Ltd
• Abyrx Inc
• Bentley Healthcare Pvt. Ltd.
• Medtronic Plc
• Ethicon, Inc
• Medline Industries, Inc
• CORMEDICA

第14章 付録

Market Overview

The Global Bone Wax Market reached US$ 65.60 million in 2023 and is expected to reach US$ 82.00 million by 2031, growing at a CAGR of 2.8% during the forecast period 2024-2031.

Bone wax is a sterile surgical product commonly used in orthopedic, neurosurgical, and thoracic surgeries. It is composed of a mixture of beeswax and petroleum jelly, sometimes with added substances like isopropyl palmitate or lanolin. Bone wax is versatile and can be applied to various bone surfaces, including those with irregularities or small defects. Its pliable nature allows for easy molding and application, making it suitable for a wide range of surgical scenarios.

Bone wax has been a standard tool in surgical practice for many years, with a proven track record of safety and efficacy. Its importance is underscored by its widespread use across different surgical specialties and its inclusion in standard surgical protocols. Bone wax facilitates surgical precision by allowing surgeons to work in a clear and blood-free environment. This clarity enhances visibility of the surgical site, enabling surgeons to perform delicate procedures with greater accuracy and confidence.

Market Dynamics: Drivers and Restraints

Increasing prevalence of sports and recreation-related injuries

Sports and recreation-related injuries often result in fractures, particularly in weight-bearing bones such as the tibia, fibula, and femur. During fracture repair surgeries, bone wax is frequently used to control bleeding from bone surfaces, especially in cases where significant soft tissue trauma is present. The increasing incidence of fractures due to sports injuries directly correlates with the demand for bone wax.

For instance, according to article published in Johns Hopkins University 2022, estimated that, in U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year, which cause some loss of time of participation, are experienced by the participants. Almost one-third of all injuries incurred in childhood are sports-related injuries.

Additionally, according to a Weinstein Legal Team report published in March 2020, stated that, nearly 30 million children and adolescents participate in youth sports in U.S. each year. This can lead to orthopedic emergencies leading to a demand for surgeries and bone wax, thus driving the market growth. Moreover, sports injuries can result in complex trauma requiring surgical intervention, such as multiple fractures, dislocations, and bone deformities.

Market Dynamics: Restraint

Emergence of alternative hemostatic agents

The development of alternative hemostatic agents, such as synthetic sealants, hemostatic gels, and advanced hemostatic powders, may pose a challenge to the growth of the bone wax market. Surgeons may opt for these newer products over traditional bone wax, particularly in cases where specific properties like rapid hemostasis or biodegradability are desired.

Alternative hemostatic agents may offer advantages over bone wax in terms of specific properties such as rapid hemostasis, ease of use, biodegradability, or enhanced safety profiles. For instance, Baxter products like Ostene bone hemostasis material is alternative to bone wax. Additionally, newer hemostatic agents may undergo rigorous testing and clinical evaluation to obtain regulatory approval, ensuring compliance with safety and efficacy standards.

Segment Analysis

The global bone wax market is segmented based on product, material, application, end-user and region.

The absorbable bone wax from the product segment accounted for approximately 61.43% of share

There is an increasing demand for biodegradable medical products across various surgical procedures. Absorbable bone wax falls into this category, as it offers the benefits of traditional bone wax without the need for removal post-surgery. For instance, innovations in material science have led to the development of absorbable bone wax made from biocompatible materials such as polysaccharides or synthetic polymers.

These materials offer effective hemostasis while being gradually absorbed by the body, eliminating the need for a secondary surgical procedure for removal. Additionally, absorbable bone wax eliminates the risks associated with traditional bone wax, such as the potential for infection or foreign body reactions. Surgeons find it convenient to use absorbable bone wax, as it simplifies the surgical process and reduces the need for additional interventions.

While absorbable bone wax may have a higher upfront cost compared to traditional bone wax, its absorbable nature eliminates the need for a second surgical procedure for removal. This can lead to cost savings for healthcare providers and patients in the long run. Thus above factors helps to boost the segment growth.

Geographical Analysis

North America accounted for approximately 39.37% of the market share in 2023

North America, particularly the United States and Canada, boasts advanced healthcare infrastructure with a high level of access to medical facilities and surgical procedures. This infrastructure supports the adoption of advanced medical technologies, including bone wax, in surgical settings.

North America experiences a high volume of surgical procedures across various specialties, including orthopedic, neurological, and cardiovascular surgeries. For instance, according to Cleveland Clinic 2022, a sternotomy procedure is very common. It's the approach cardiac surgeon's use most often for coronary artery bypass surgery and other heart surgeries. Surgeons perform more than 700,000 sternotomies each year in the United States.

Additionally, United States, in particular, has one of the highest healthcare expenditures globally. This substantial healthcare spending creates a conducive environment for the adoption of advanced medical technologies, including bone wax, in surgical practice. Thus, above factors help to boost the region growth.

COVID-19 Impact Analysis

While elective surgeries declined, there was an increased focus on emergency and life-saving procedures, including certain cardiovascular surgeries. Bone wax continued to be essential in these emergency surgeries to control bleeding and facilitate wound closure. The pandemic underscored the importance of infection control measures in healthcare settings.

Surgeons and healthcare facilities may have become more vigilant about using sterile surgical products, including bone wax, to minimize the risk of surgical site infections and other complications. To reduce the risk of virus exposure and conserve resources, there was a trend towards performing minimally invasive procedures when possible.

While bone wax is primarily used in open surgeries like sternotomy, the overall shift towards minimally invasive techniques could have affected the demand for traditional bone wax. As vaccination efforts expanded and healthcare systems adapted to the pandemic, many regions experienced a gradual recovery in elective surgeries. This likely led to a rebound in demand for bone wax and other surgical products as surgical volumes returned to pre-pandemic levels.

Competitive Landscape

The major global players in the market include B. Braun SE, Cura Medical, Dolphin Sutures, GPC Medical Ltd, Abyrx Inc, Bentley Healthcare Pvt. Ltd., Medtronic Plc, Ethicon, Inc, Medline Industries, Inc, CORMEDICA, among others.

Why Purchase the Report?

To visualize the global bone wax market segmentation based on product, material, application, end-user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of bone wax market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global bone wax market report would provide approximately 69 tables, 58 figures and 187 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Material
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Market Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing prevalence of sports and recreation-related injuries
    • 4.1.1.2. Rising technological advancements of the products
• 4.2. Restraints
  • 4.2.1. Emergence of alternative hemostatic agents
  • 4.2.2. Opportunity
  • 4.2.3. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Unmet Needs
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Absorbable Bone Wax *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Non-absorbable Bone Wax

8. By Material

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 8.1.2. Market Attractiveness Index, By Material
• 8.2. Natural Bone Wax *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Synthetic Bone Wax

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Thoracic Surgery *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Orthopedic Surgery
• 9.4. Dental/Oral Surgery
• 9.5. Neurosurgery
• 9.6. Others

10. By End-User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.1.2. Market Attractiveness Index, By End-User
• 10.2. Hospitals*
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Specialty Clinics
• 10.4. Ambulatory Surgical Centers
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1. U.S.
    • 11.2.7.2. Canada
    • 11.2.7.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1. Germany
    • 11.3.7.2. UK
    • 11.3.7.3. France
    • 11.3.7.4. Italy
    • 11.3.7.5. Spain
    • 11.3.7.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1. Brazil
    • 11.4.7.2. Argentina
    • 11.4.7.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1. China
    • 11.5.7.2. India
    • 11.5.7.3. Japan
    • 11.5.7.4. South Korea
    • 11.5.7.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. B. Braun SE *
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Cura Medical
• 13.3. Dolphin Sutures
• 13.4. GPC Medical Ltd
• 13.5. Abyrx Inc
• 13.6. Bentley Healthcare Pvt. Ltd.
• 13.7. Medtronic Plc
• 13.8. Ethicon, Inc
• 13.9. Medline Industries, Inc
• 13.10. CORMEDICA (LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us